Study links Wegovy to increased hair loss risk




Researchers assessed data from 16 million patients from 2006 to 2020 taking semaglutide-based drugs; the active ingredient in Wegovy.




Source link

Show Comments (0) Hide Comments (0)
Leave a comment

Your email address will not be published. Required fields are marked *